Rallybio Corp (RLYB)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Rallybio Corp reported revenue of $858.0K, up 34.9% from the prior year. The company ran a net loss, with a net margin of -1046.4%. It held $62.26M in total assets against $4.30M in total liabilities.
Key ratios (FY2025)
-3853.6%
Operating margin
-1046.4%
Net margin
-15.5%
Return on equity
+34.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $858.0K | $636.0K | — | — | — | — | — |
| Operating Income | -$33.06M | -$60.50M | -$78.93M | -$67.88M | -$45.65M | -$25.30M | — |
| Net Income | -$8.98M | -$57.77M | -$74.56M | -$66.65M | -$47.01M | -$26.45M | — |
| EPS (Diluted) | $-1.59 | $-10.61 | $-1.84 | $-2.09 | $-1.84 | — | — |
| Total Assets | $62.26M | $68.11M | $115.62M | $180.44M | $182.19M | $141.86M | — |
| Total Liabilities | $4.30M | $6.45M | $9.44M | $11.12M | $6.58M | $5.86M | — |
| Shareholders' Equity | $57.96M | $61.65M | $106.18M | $169.32M | $175.60M | $136.00M | $16.86M |
| Cash & Equivalents | $31.37M | $13.90M | $24.49M | $56.96M | $175.33M | $140.23M | — |
| Operating Cash Flow | -$29.81M | -$49.28M | -$60.27M | -$57.28M | -$45.53M | -$22.04M | — |
| Capital Expenditures | — | $0 | $12.0K | $54.0K | $333.0K | $137.0K | — |
| Shares Outstanding | 5.28M | 5.19M | 37.83M | 37.84M | 32.13M | 23.41M | — |